DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages


Schwannoma pathology

Author: Assoc Prof Patrick Emanuel, Dermatopathologist, Auckland, New Zealand, 2013.

Table of contents

Schwannoma is also known as an “neurilemmoma”, “neurolemmoma”, and “Schwann cell tumour”. It is a benign peripheral nerve sheath tumour composed of Schwann cells. Schwann cells normally produce the insulating myelin sheath covering peripheral nerves.

Histology of schwannoma

In schwannoma, sections show an encapsulated well-circumscribed lesion beneath the uninterrupted epidermis. The tumour is composed of different areas composed of different cellular densities. More cellular areas (Antoni A, figure 1) are composed of a haphazard arrangement of bland cells with spindled and oval nuclei. Loose, less cellular areas (Antoni B, figure 2) are composed of a loose oedematous and mucinous stroma with fibrillar collagen. The vessels are prominent and often surrounded by a dense sclerosis.

Characteristic Verocay bodies may be seen (figure 3). These consist of parallel columns of elongated nuclei on either side of a homogeneous acellular material.

An associated peripheral nerve can usually be seen.

Occasionally, “ancient change” or cellular atypia believed to be a reactive phenomenon may be seen (figure 4).

Schwannoma pathology

Special studies for schwannoma

Schwannomas are strongly positive with S100.

Differential diagnosis of schwannoma pathology

Neurofibroma – Lacks the Antoni A and B pattern of schwannoma and is not encapulated. Plexiform neurofibroma may resemble schwannoma. Neurofibromas typically have nerves coursing through the mass which can be demonstrated with immunohistochemical staining with neurofilament.

Perineurioma – These are EMA positive and S100 negative.

Dermatofibromasarcoma protuberans – These are positive with CD34, lack S100 positivity and lacks the Antoni A and B pattern of schwannoma. Additionally, they are not encapulated.



Related information

Sign up to the newsletter